Received Feb 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y017062 | — |
No additional AE/no PQC reported; Customer called to report TE. Vaccines were administered to patients. Symptoms were not reported. Permission to contact was granted. AE was filled in case #s 02952625; 02952673; 02952674; 02952675; 02952676; 02952677; 02952678; 02952679; 02952680; 02; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 03-Feb-2026, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), lot #Y017062 has been verified to be a valid lot number, expiration date: 11-Oct-2026, administered for prophylaxis (dose, route of administration and anatomical site of injection were not reported). The vaccine was reconstituted with sterile diluent solution for injection (Hollister-Stier STERILE DILUENT), (lot # and expiration date were not reported). The reconstituted vaccine underwent a temperature excursion, being exposed to temperatures between -14°C and -10°C (reported as -13.6°C) for a duration of 2 hours, 5 minutes, and 0 seconds (Improper storage of product in use). No additional adverse event was reported (no adverse event).
MERCK STERILE DILUENT